Petition to Ban Third Generation Oral Contraceptives Containing Desogestrel

February 6, 2007

View as PDF.

It is estimated that women in the U.S. filled more than 7.5 million prescriptions for third generation oral contraceptives this past year (November 2005 to October 2006) (IMS, National Prescription Audit). By banning third generation oral contraceptives, the FDA will potentially save hundreds of young women a year from developing venous thrombosis and its disabling and sometimes fatal consequences.

January 11, 2013, View the FDA Response Letter.

PCF ID: 
532
Displayed Title: 
Petition to the FDA to Ban Third Generation Oral Contraceptives Containing Desogestrel Due to Increased Risk of Venous Thrombosis (HRG Publication #1799)